All Medicines
Dr. Aditya Singh

Medically Reviewed By

Dr. Aditya Singh, MBBS, MD (Pharmacology)

Reg No: MCI-654321 • Verified Medical Reviewer

Angiotensin Ii Antagonists Combined With Anti Hypertensives

Telmikind-Trio 6.25 Tablet

(Telmisartan (40mg) + Cilnidipine (10mg) + Chlorthalidone (6.25mg))

Uses, side effects, dosage information & price range

Mankind Pharma Ltd70.12

About this medicine

Telmikind-Trio 6.25 Tablet is a combination of medicines used to treat hypertension (high blood pressure) when a single medication is not effective. It helps to lower high blood pressure thus reduces chances of future heart attack and stroke.Telmikind-Trio 6.25 Tablet should be taken with food. The

What are the side effects of Telmisartan (40mg) + Cilnidipine (10mg) + Chlorthalidone (6.25mg) (Telmikind-Trio 6.25 Tablet)?

Not everyone experiences these side effects. Consult your doctor if any persist.

  • Ankle swelling
  • Headache
  • Dizziness
  • Tiredness
  • Palpitations

Common Brand Names for this Composition

The following popular commercial brand names contain Telmisartan (40mg) + Cilnidipine (10mg) + Chlorthalidone (6.25mg) as their active ingredient composition:

Telmikind-Trio 6.25 Tablet

Mankind Pharma Ltd

MRP₹70.12

Key Information

Salt / Composition

Telmisartan (40mg) + Cilnidipine (10mg) + Chlorthalidone (6.25mg)

Category

Angiotensin Ii Antagonists Combined With Anti Hypertensives

Manufacturer

Mankind Pharma Ltd

Price (MRP)

70.12

Need a doctor's consultation?

Don't self-medicate. Consult a doctor before taking any medicine.

Medical Disclaimer

This information is for educational purposes only and is not a substitute for professional medical advice. Always consult your doctor or pharmacist before taking any medication. Prices are indicative and may vary. Do not start, stop, or change the dosage of any medicine without your doctor's approval.

Disclaimer:Content on this page is for informational purposes only. Do not consume prescription medication without a registered practitioner's direct oversight.